ACHV

Achieve Life Sciences Inc

7.24

Oct 02 • 3:59 PM ET -0.29 (-3.85%)

7.34

Aftermarket • 7:30 PM ET +0.10 (1.33%)

Healthcare Biotechnology USA Small NASD

Oct 01, 8:37 AMAchieve Life Sciences names former Esperion executive Benjamin Halladay CFO, succeeding Mark Oki effective October 5, 2026

Peers: INCY BMRN VKTX KRYS KYMR RYTM CRNX AXSM MDGL NBIX

| Held by: VTI XBI IWM VXF SURI IWO VTWO FESM IWC DWAS

Scroll to Statements

Index	RUT
Market Cap	745.01M
Enterprise Value	572.66M
Income	-114.04M
Sales	0.00M
Book/sh	-0.14
Cash/sh	1.82
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	28
IPO	Oct 12, 1995

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	-
P/C	3.98
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	0.95
Current Ratio	0.95
Debt/Eq	-
LT Debt/Eq	-
Option/Short	Yes / Yes

EPS (ttm)	-1.55
EPS next Y	-0.68
EPS next Q	-0.20
EPS this Y	-16.80%
EPS next Y	53.60%
EPS next 5Y	-
EPS past 3/5Y	32.06% 25.38%
Sales past 3/5Y	- -
EPS Y/Y TTM	-6.14%
Sales Y/Y TTM	-
EPS Q/Q	-118.05%
Sales Q/Q	-
Earnings	Aug 11 BMO
EPS/Sales Surpr.	-385.14% -

Insider Own	32.16%
Insider Trans	-0.06%
Inst Own	56.41%
Inst Trans	48.64%
ROA	-91.46%
ROE	-844.99%
ROIC	-
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	-5.82%
SMA50	-2.67%
SMA200	33.06%
Trades

Shs Outstand	102.72M
Shs Float	69.81M
Short Float	22.91%
Short Ratio	10.94
Short Interest	15.99M
52W High	8.64 -16.20%
52W Low	2.62 176.34%
Volatility	6.19% 5.49%
ATR (14)	0.44
RSI (14)	43.15
Beta	2.41
Rel Volume	1.29
Avg Volume	1.46M
Volume	1,886,305

Perf Week	-3.98%
Perf Month	-14.62%
Perf Quarter	12.25%
Perf Half Y	124.15%
Perf YTD	45.67%
Perf Year	126.96%
Perf 3Y	70.35%
Perf 5Y	-14.32%
Perf 10Y	-99.35%
Recom	1.00
Target Price	14.58
Prev Close	7.53
Price	7.24
Change %	-3.85%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-30-26	Initiated	Stifel	Buy	$18
Aug-13-26	Initiated	Morgan Stanley	Overweight	$13
Jun-26-26	Resumed	Raymond James	Strong Buy	$20
Apr-21-26	Initiated	Canaccord Genuity	Buy	$13
Nov-25-25	Initiated	Citizens JMP	Mkt Outperform	$19
Aug-21-25	Initiated	H.C. Wainwright	Buy	$12
Nov-14-24	Initiated	Rodman & Renshaw	Buy	$12
Sep-27-24	Initiated	Raymond James	Strong Buy	$20
May-10-23	Reiterated	Maxim Group	Buy	$8 → $20
Jun-23-21	Initiated	Oppenheimer	Outperform	$23

Oct-01-26 08:30AM	Achieve Life Sciences Appoints Benjamin Halladay as Chief Financial Officer (GlobeNewswire) -6.92%
Sep-28-26 08:30AM	Achieve Life Sciences to Present 52-Week Cytisinicline Efficacy Data for Smoking and E-Cigarette Cessation at CHEST 2026 (GlobeNewswire)
Sep-03-26 05:15PM	Achieve Life Sciences Announced Granting of New Hire Inducement Awards (GlobeNewswire)
Aug-11-26 08:30AM	Achieve Life Sciences Reports Second Quarter 2026 Financial Results and Provides Business Updates (GlobeNewswire)
Aug-03-26 08:30AM	Achieve Life Sciences Appoints Ronald Dadino and Gloria Cosgrove to Lead CMC, Supply Chain, and Quality (GlobeNewswire)
08:30AM	Loading…
Jul-31-26 08:30AM	Achieve Life Sciences Announced Granting of New Hire Inducement Awards (GlobeNewswire)
Jun-29-26 08:30AM	Achieve Life Sciences Joins Russell 2000 Index (GlobeNewswire)
Jun-22-26 08:30AM	Achieve Life Sciences Receives Complete Response Letter from FDA for Cytisinicline NDA (GlobeNewswire) +5.15%
Jun-02-26 08:30AM	Achieve Life Sciences Appoints Jeffrey Farrow and Reid Waldman, MD to Board of Directors (GlobeNewswire) -5.09%
May-19-26 02:15PM	Achieve Life Sciences Presents Safety Data from 52 Weeks of Continuous Cytisinicline Treatment (GlobeNewswire) -6.71%
May-12-26 07:04PM	Achieve Life Sciences Inc (ACHV) Q1 2026 Earnings Call Highlights: Strategic Financing and ... (GuruFocus.com) +7.16%
12:55PM	Achieve Life Sciences, Inc. Q1 2026 Earnings Call Summary (Moby)
07:05AM	Achieve Life Sciences Strengthens Board and Commercial Leadership with Three Senior Appointments from Team Previously at Verona Pharma (GlobeNewswire)
07:00AM	Achieve Life Sciences Reports First Quarter 2026 Financial Results and Provides Business Updates (GlobeNewswire)
May-05-26 08:30AM	Achieve Life Sciences to Announce First Quarter 2026 Financial Results and Host Conference Call and Webcast on May 12, 2026 (GlobeNewswire)
08:57AM	Loading…
Apr-16-26 08:57AM	Achieve Life Sciences Announces Appointment of Andrew D. Goldberg, MD, as Chief Executive Officer and to the Board of Directors (GlobeNewswire) +35.49%
08:53AM	Achieve Life Sciences Announces Up to $354 Million Private Placement (GlobeNewswire)
Apr-15-26 08:00AM	Achieve Life Sciences Announces Operational Progress Including Completion of Technology Transfer to Adare Pharma Solutions (GlobeNewswire)
Mar-26-26 08:30AM	Achieve Life Sciences Announces Publication in Nicotine & Tobacco Research Linking Cytisinicline's Receptor Selectivity to Low Nausea Rates and Favorable Tolerability (GlobeNewswire)
Mar-25-26 08:30AM	Achieve Life Sciences, Inc. Q4 2025 Earnings Call Summary (Moby)
Mar-24-26 03:02PM	Achieve Life Sciences Inc (ACHV) Q4 2025 Earnings Call Highlights: Strategic Advances and ... (GuruFocus.com) -28.40%
02:23PM	Achieve Life Sciences Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses (Newsfile)
07:00AM	Achieve Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates (GlobeNewswire)
Mar-17-26 08:30AM	Achieve Life Sciences to Announce Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call and Webcast on March 24, 2026 (GlobeNewswire)
Mar-04-26 08:00AM	Achieve Life Sciences Presents Data at SRNT Demonstrating Successful Cessation in Smokers with Extensive Prior Treatment Exposure; and on Participant Experience in the ORCA-OL Study (GlobeNewswire) +5.77%
Feb-02-26 07:32PM	Achieve Life Sciences, Inc. (ACHV): A Bull Case Theory (Insider Monkey)
Jan-30-26 04:05PM	Achieve Life Sciences Announced Granting of New Hire Inducement Awards (GlobeNewswire)
Jan-12-26 08:47AM	Achieve Life Sciences Confirms Promotion of Dr. Mark Rubinstein to Chief Medical Officer (GlobeNewswire)
Dec-17-25 04:11PM	Achieve Life Sciences to Host Meetings During the J.P. Morgan Healthcare Conference Week (PR Newswire)
Dec-08-25 04:10PM	Achieve Life Sciences Announced Granting of New Hire Inducement Awards (GlobeNewswire)
08:40AM	Loading…
Nov-25-25 08:40AM	FDA Accepts Achieve Life Sciences, Inc. (ACHV) NDA Application for Cytisinicline in Smoking Cessation (Insider Monkey) +15.62%
Nov-06-25 04:01PM	Achieve Life Sciences Inc (ACHV) Q3 2025 Earnings Call Highlights: Strategic Advances and ... (GuruFocus.com)
07:00AM	Achieve Life Sciences Reports Third Quarter 2025 Financial Results; Provides Updates on Cytisinicline Program (GlobeNewswire)
Nov-03-25 08:30AM	Achieve Life Sciences Meets Key Milestones Advancing Cytisinicline NDA for Smoking Cessation (GlobeNewswire)
Oct-29-25 08:30AM	Achieve Life Sciences to Announce Third Quarter Financial Results and Host Conference Call and Webcast on November 6, 2025 (GlobeNewswire)
Oct-22-25 03:31PM	Achieve Life Sciences, Inc. (ACHV): A Bull Case Theory (Insider Monkey)
Oct-20-25 08:30AM	Achieve Life Sciences Appoints Erik Atkisson as Chief Legal Officer (GlobeNewswire) +19.05%
08:25AM	FDA Grants First CNPV Vouchers, Igniting Rally in Biotech Stocks (GuruFocus.com)
Oct-17-25 04:21PM	The FDA Just Granted Its Speediest Review Ever. Disc Medicine, Others Fly. (Investor's Business Daily) +36.36%
07:30AM	Achieve Life Sciences Receives FDA Commissioner's National Priority Voucher for Cytisinicline for Treatment of Nicotine Dependence for E-cigarette or Vaping Cessation (GlobeNewswire)
Oct-02-25 04:01PM	Achieve Life Sciences Announces Granting of New Hire Inducement Awards (GlobeNewswire)
Sep-22-25 08:30AM	Achieve Life Sciences Announces Publication in Thorax of Data Demonstrating Cytisinicline's Potential Efficacy and Tolerability for Smoking Cessation in Individuals with COPD (GlobeNewswire)
Sep-18-25 08:30AM	Achieve Life Sciences Promotes Craig Donnelly to Chief Operations Officer (GlobeNewswire)
Sep-11-25 05:01PM	Achieve Life Sciences Names Dr. Mark Rubinstein Interim Chief Medical Officer (GlobeNewswire)
Sep-03-25 08:30AM	Achieve Life Sciences Announces FDA Acceptance of Cytisinicline New Drug Application for Treatment of Nicotine Dependence for Smoking Cessation (GlobeNewswire)
Sep-02-25 08:30AM	Achieve Life Sciences Announces Participation at Upcoming Investor Conferences (GlobeNewswire)
Aug-25-25 10:30AM	BC-Most Active Stocks (Associated Press Finance) +13.36%
Aug-21-25 02:11PM	Achieve Life Sciences Inches Closer To FDA Nod For First New Quit-Smoking Drug In 20 Years (Benzinga) +12.02%
Aug-07-25 07:30AM	Achieve Life Sciences Reports Second Quarter 2025 Financial Results; Provides Updates on Cytisinicline Program (GlobeNewswire)
Jul-29-25 08:30AM	Achieve Life Sciences to Participate in the BTIG Virtual Biotechnology Conference (GlobeNewswire) -5.20%
Jul-24-25 08:30AM	Achieve Life Sciences to Announce Second Quarter Financial Results and Host Conference Call and Webcast on August 7, 2025 (GlobeNewswire)
Jul-13-25 06:15AM	Raymond James Predicts Up to ~760% Surge for These 2 Strong Buy Stocks (TipRanks)
Jul-07-25 08:56AM	Should You Hold Achieve Life Sciences (ACHV)? (Insider Monkey) -5.05%
Jul-06-25 04:00AM	Omnicom, Achieve Life Sciences Partner for AI-Driven Launch of New Nicotine Dependence Treatment (Insider Monkey)
Jun-30-25 07:52PM	Achieve Life Sciences Announces Closing of Public Offering of Common Stock and Partial Exercise of Underwriters' Option to Purchase Additional Securities (GlobeNewswire)
Jun-26-25 11:43PM	Achieve Life Sciences Announces Pricing of $45.0 Million Underwritten Public Offering (GlobeNewswire) -7.63% -36.47%
04:03PM	Achieve Life Sciences Announces Proposed Underwritten Public Offering (GlobeNewswire)
04:02PM	Achieve Life Sciences Announces Partnership with Omnicom to Execute Integrated, Data-Driven Launch of the First Potential New Treatment for Nicotine Dependence in Nearly Two Decades (GlobeNewswire)
04:01PM	Achieve Life Sciences Announces Submission of NDA to FDA for Cytisinicline as a Treatment of Nicotine Dependence for Smoking Cessation (GlobeNewswire)
May-28-25 08:30AM	Achieve Life Sciences to Present at the Jefferies Global Healthcare Conference (GlobeNewswire)
May-20-25 08:30AM	Achieve Life Sciences to Present New Data at the 2025 ATS International Conference Demonstrating that Cytisinicline Reduced Cravings and Nicotine Intake (GlobeNewswire)
May-14-25 03:06AM	Achieve Life Sciences Inc (ACHV) Q1 2025 Earnings Call Highlights: Strategic Advances Amid ... (GuruFocus.com) -6.42%
01:56AM	Q1 2025 Achieve Life Sciences Inc Earnings Call (Thomson Reuters StreetEvents)
May-13-25 07:30AM	Achieve Life Sciences Reports First Quarter 2025 Financial Results and Highlights Updates in Cytisinicline Program (GlobeNewswire) +6.85%
May-06-25 08:30AM	Achieve Life Sciences to Announce First Quarter 2025 Financial Results and Host Conference Call and Webcast on May 13, 2025 (GlobeNewswire) -6.25%
Apr-22-25 11:26AM	Achieve Life Sciences announces publication of results from Phase 3 ORCA-3 trial (TipRanks) +10.22%
Apr-21-25 11:19AM	Achieve Life Sciences Announces Cytisinicline Phase 3 ORCA-3 Trial Publication on Smoking Cessation in JAMA Internal Medicine (GlobeNewswire) +13.07%
Mar-20-25 06:25PM	Achieve Life Sciences, Inc. (ACHV): A Bull Case Theory (InsiderMonkey)
Mar-12-25 03:14AM	Q4 2024 Achieve Life Sciences Inc Earnings Call (Thomson Reuters StreetEvents) -9.25%
03:02AM	Achieve Life Sciences Inc (ACHV) Q4 2024 Earnings Call Highlights: Strategic Advances Amid ... (GuruFocus.com)
Mar-11-25 07:30AM	Achieve Life Sciences Reports Financial Results for Fourth Quarter and Year-End 2024 and Provides Update on the Cytisinicline Development Program (GlobeNewswire)
Mar-07-25 08:30AM	Achieve Life Sciences to Present at the Barclays 27th Annual Global Healthcare Conference (GlobeNewswire)
Mar-06-25 08:30AM	Achieve Life Sciences to Announce Fourth Quarter and Year-End 2024 Financial Results and Host Conference Call and Webcast on March 11, 2025 (GlobeNewswire) +9.03%
Feb-18-25 07:29AM	Here are Rogue Funds Updates on Achieve Life Sciences (ACHV) (Insider Monkey)
Feb-11-25 08:30AM	Achieve Life Sciences to Present at the Oppenheimer Healthcare Life Sciences Conference (GlobeNewswire)
Feb-10-25 08:30AM	Achieve Life Sciences Announces Positive Outcome of Second Data Safety Monitoring Committee Review for the ORCA-OL Clinical Trial (GlobeNewswire) +15.74%
Jan-24-25 12:14PM	Achieve Life Sciences, Inc. (ACHV): A Bull Case Theory (Insider Monkey)
Jan-10-25 08:30AM	Achieve Life Sciences Appoints Dr. Kristen Slaoui and Nancy Phelan to its Board of Directors (GlobeNewswire)
Jan-07-25 08:30AM	Achieve Life Sciences Announces Critical Milestone Successfully Reached in ORCA-OL Cytisinicline Clinical Trial Required for NDA Submission (GlobeNewswire) +5.07%
Jan-06-25 08:30AM	Achieve Life Sciences to Host Meetings During the J.P. Morgan Healthcare Conference Week (GlobeNewswire)
Jan-02-25 11:04AM	Should You Expect a Strong Re-rating for Achieve Life Sciences (ACHV) Post Results in Q1? (Insider Monkey)
Dec-09-24 08:30AM	Achieve Life Sciences Appoints Mark Oki as Chief Financial Officer (GlobeNewswire)
Dec-03-24 08:30AM	Achieve Life Sciences to Advance First Vaping Cessation Therapy After Successful End-of-Phase 2 Meeting with FDA (GlobeNewswire)
Nov-14-24 08:30AM	Achieve Life Sciences Announces Participation at Upcoming Investor Conferences (GlobeNewswire)
Nov-08-24 02:01PM	Achieve Life Sciences Inc (ACHV) Q3 2024 Earnings Call Highlights: Strategic Advances Amid ... (GuruFocus.com) -7.40%
Nov-07-24 04:05PM	Achieve Life Sciences Reports Financial Results for Third Quarter 2024 and Provides Corporate Update (GlobeNewswire)
Oct-24-24 08:00AM	Achieve Life Sciences to Announce Third Quarter Financial Results and Host Conference Call and Webcast on November 7, 2024 (GlobeNewswire)
Oct-23-24 08:00AM	Achieve Life Sciences President and CMO, Dr. Cindy Jacobs, Speaks at FDA and NIH Smoking Cessation Public Meeting (GlobeNewswire)
Oct-16-24 08:00AM	Achieve Life Sciences Promotes Jaime Xinos to Chief Commercial Officer to Advance Commercial Readiness of Cytisinicline (GlobeNewswire)
Oct-10-24 08:00AM	Achieve Life Sciences Announces Completion of Enrollment in ORCA-OL Clinical Trial & Successful Outcome of the First Data Safety Monitoring Committee Meeting (GlobeNewswire)
Oct-01-24 08:45AM	Achieve Life Sciences Strengthens Leadership with Appointment of Dr. Mark Rubinstein, Nicotine Dependence Expert, as New Head of Medical Affairs (GlobeNewswire)
Aug-26-24 04:30PM	Achieve Life Sciences Announces Changes in Executive Leadership and Board of Directors (GlobeNewswire)
Aug-13-24 04:01PM	Achieve Life Sciences Reports Financial Results for Second Quarter 2024 and Provides Corporate Update (GlobeNewswire)
Jul-31-24 08:00AM	Achieve Life Sciences Announces FDA Grants Breakthrough Therapy Designation to Cytisinicline for the Treatment of E-Cigarette or Vaping Nicotine Dependence (GlobeNewswire)
Jul-29-24 08:00AM	Achieve Life Sciences Announces $20M Loan Refinancing with Silicon Valley Bank (GlobeNewswire)
Jul-25-24 08:00AM	Achieve Life Sciences to Announce Second Quarter Financial Results and Host Conference Call and Webcast on August 13, 2024 (GlobeNewswire)
Jul-15-24 08:00AM	Milestone Pharmaceuticals Refreshes Board of Directors (GlobeNewswire)
Jul-09-24 08:00AM	Achieve Life Sciences to Present at JonesHealthcare Seaside Summit 2024 (GlobeNewswire)
Jul-01-24 08:00AM	Achieve Life Sciences Announces Addition to the U.S. Russell 3000 and Russell Microcap Indexes (GlobeNewswire)
May-29-24 08:00AM	Achieve Life Sciences Announces Initiation of ORCA-OL Clinical Trial Evaluating Long-Term Exposure of Cytisinicline in People who Smoke or Use Nicotine E-Cigarettes (GlobeNewswire)

Achieve Life Sciences, Inc. is a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of nicotine dependence. Its products include cytisine, a plant-based alkaloid with a binding affinity to the nicotinic acetylcholine receptor. The company was founded in October 1991 and is headquartered in Bothell, WA.

Chief Legal OfficerMr. Erik Atkisson

CEODr. Andrew D. Goldberg M.D.

Chief Financial OfficerMr. Mark K. Oki CPA

VP of Finance & Principal Accounting OfficerMr. Jerry Wan

Chief Medical OfficerDr. Mark L. Rubinstein M.D.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Stewart Richard Alistair	Director	Aug 19 '26	Sale	8.49	20,626	175,177	208,249	Aug 21 04:30 PM
Stewart Richard Alistair	Director	Aug 19 '26	Proposed Sale	7.52	20,626	155,108		Aug 19 09:16 AM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ACHV

Achieve Life Sciences Inc

Upgrade your Finviz experience